134 related articles for article (PubMed ID: 12792793)
1. TP53 mutations in primary breast carcinomas from white and African-Brazilian patients.
Nagai MA; Schaer Barbosa H; Zago MA; Araújo Silva W; Nishimoto IN; Salaorni S; Guerreiro Costa LN; Silva Araújo M; Caldas Oliveira AG; Mourâo Neto M; Brentani MM
Int J Oncol; 2003 Jul; 23(1):189-96. PubMed ID: 12792793
[TBL] [Abstract][Full Text] [Related]
2. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
[TBL] [Abstract][Full Text] [Related]
3. BRCA1 and TP53 mutation spectrum of breast carcinoma in an ethnic population of Kashmir, an emerging high-risk area.
Eachkoti R; Hussain I; Afroze D; Aejazaziz S; Jan M; Shah ZA; Das BC; Siddiqi MA
Cancer Lett; 2007 Apr; 248(2):308-20. PubMed ID: 16996204
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer.
Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR
Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522
[TBL] [Abstract][Full Text] [Related]
5. High frequency of G/C transversion on p53 gene alterations in breast cancers from Taiwan.
Chen FM; Hou MF; Wang JY; Chen TC; Chen DC; Huang SY; Chung YS; Lin SR
Cancer Lett; 2004 Apr; 207(1):59-67. PubMed ID: 15050734
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa.
Vos M; Adams CH; Victor TC; van Helden PD
Cancer Genet Cytogenet; 2003 Jan; 140(1):23-30. PubMed ID: 12550754
[TBL] [Abstract][Full Text] [Related]
7. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
8. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
[TBL] [Abstract][Full Text] [Related]
9. Frequency and pattern of p53 gene mutation in a cohort of Spanish women with node-negative breast cancer.
Meng L; Lin L; Fresno M; Morales AR; Nadji M
Int J Oncol; 1999 Sep; 15(3):555-8. PubMed ID: 10427139
[TBL] [Abstract][Full Text] [Related]
10. Racial disparity in the association of p53 gene alterations with breast cancer survival.
Shiao YH; Chen VW; Scheer WD; Wu XC; Correa P
Cancer Res; 1995 Apr; 55(7):1485-90. PubMed ID: 7882357
[TBL] [Abstract][Full Text] [Related]
11. TP53 mutation is an independent prognostic marker for poor outcome in both node-negative and node-positive breast cancer.
Overgaard J; Yilmaz M; Guldberg P; Hansen LL; Alsner J
Acta Oncol; 2000; 39(3):327-33. PubMed ID: 10987229
[TBL] [Abstract][Full Text] [Related]
12. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients.
Berns EM; Klijn JG; Smid M; van Staveren IL; Look MP; van Putten WL; Foekens JA
Genes Chromosomes Cancer; 1996 Jul; 16(3):170-9. PubMed ID: 8814449
[TBL] [Abstract][Full Text] [Related]
13. TP53 mutations in upper aerodigestive squamous cell carcinomas from a group of Brazilian patients.
Nagai MA; Miracca EC; Yamamoto L; Kowalski LP; Brentani RR
Am J Surg; 1995 Nov; 170(5):492-4. PubMed ID: 7485740
[TBL] [Abstract][Full Text] [Related]
14. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
Chang MY; Chong IW; Chen FM; Wang JY; Cheng TL; Cheng YJ; Sheu CC; Hung SY; Yang MC; Lin SR
Cancer Lett; 2005 May; 222(2):195-204. PubMed ID: 15863268
[TBL] [Abstract][Full Text] [Related]
15. Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells.
Hietanen SH; Kurvinen K; Syrjänen K; Grénman S; Carey T; McClatchey K; Syrjänen S
Am J Obstet Gynecol; 1995 Nov; 173(5):1477-82. PubMed ID: 7503188
[TBL] [Abstract][Full Text] [Related]
16. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
[TBL] [Abstract][Full Text] [Related]
17. Characterization of p53 gene mutations in a Brazilian population with oral squamous cell carcinomas.
Chaves AC; Cherubini K; Herter N; Furian R; Santos DS; Squier C; Domann FE
Int J Oncol; 2004 Feb; 24(2):295-303. PubMed ID: 14719105
[TBL] [Abstract][Full Text] [Related]
18. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
Huang C; Taki T; Adachi M; Konishi T; Higashiyama M; Miyake M
Oncogene; 1998 May; 16(19):2469-77. PubMed ID: 9627113
[TBL] [Abstract][Full Text] [Related]
19. Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.
Newman B; Mu H; Butler LM; Millikan RC; Moorman PG; King MC
JAMA; 1998 Mar; 279(12):915-21. PubMed ID: 9544765
[TBL] [Abstract][Full Text] [Related]
20. Mutation analysis of BRCA1 gene in African-American patients with breast cancer.
Shen D; Wu Y; Subbarao M; Bhat H; Chillar R; Vadgama JV
J Natl Med Assoc; 2000 Jan; 92(1):29-35. PubMed ID: 10800284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]